TRIDENT PHARMACEUTICALS, INC. Patent applications |
Patent application number | Title | Published |
20130345114 | Agent for Treating Allergic or Hypersensitivity Condition - The use of an agent in the manufacture of a medicament to affect an allergic condition and/or a hypersensitivity condition is described. The agent is capable of modulating a ganglioside associated activity. The agent is not coupled to an antigen. The modulation of the ganglioside associated activity affects an allergic condition and/or a hypersensitivity condition. | 12-26-2013 |
20120003267 | Therapeutic Agents - A method for treating an rheumatoid arthritis in a mammalian subject in need of same wherein the method comprises: administering to the mammalian subject an agent capable of modulating a ganglioside GM-1 associated activity in an amount effective to treat the disease. | 01-05-2012 |
20100136023 | THERAPEUTIC AGENTS - A method for treating an rheumatoid arthritis in a mammalian subject in need of same wherein the method comprises: administering to the mammalian subject an agent capable of modulating a ganglioside GM-1 associated activity in an amount effective to treat the disease. | 06-03-2010 |